Calif. Pharmacies Sue Pfizer, Ranbaxy Over Lipitor Deal

Law360, New York (November 8, 2011, 10:01 PM EST) -- Eleven California pharmacies sued Pfizer Inc., generics maker Ranbaxy Pharmaceuticals Inc. and others on Monday, saying an anti-competitive agreement between the drug companies forced them to pay higher prices for the cholesterol treatment Lipitor for longer than necessary.

The agreement between Pfizer and Ranbaxy — which was the first company to challenge Pfizer's patents on Lipitor when it filed its abbreviated new drug application nine years ago — has delayed the entry of generic versions of Lipitor into the U.S. market for up to 20 months...
To view the full article, register now.




Case Information

Case Title

Chimes Pharmacy, Inc et al v. Pfizer, Inc., et al.,

Case Number



California Northern

Nature of Suit



Jeffrey S. White

Date Filed

November 7, 2011


Government Agencies

UK Financial Services

UK Financial Services

Read Our Latest UK Financial Services Coverage

Financial Services Law360 UK provides breaking news and analysis on the financial sector. Coverage includes UK and European Union policy, enforcement, and litigation involving banks, asset management firms, and other financial services organizations.